Mirelle 0,015 mg/0,06 mg Coated tablet
PDF Leaflet Revision Date: 3 August 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Oral contraception.
Dosage (summary)
One tablet daily for 28 days.
Special Populations
- Paediatric patients
- Geriatric patients
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; may reduce breast milk quantity.
Key Drug Interactions
- Enzyme inducers (e.g., phenytoin, rifampicin)
- CYP3A4 inhibitors (e.g., azole antifungals)
Contraindications
- Hypersensitivity to active substances
- History of thromboembolic events
- Severe hepatic disease
- Undiagnosed vaginal bleeding
- Known or suspected pregnancy
Common side effects
- Nausea
- Abdominal pain
- Headache
- Depressed mood
- Breast tenderness
Counselling Points
- Take at the same time daily
- Use barrier method if tablets missed
- Consult physician for mood changes
Serious warnings
- Increased risk of thromboembolic events
- Monitor for migraine exacerbation
- May influence glucose tolerance
Important Disclaimer
The Mirelle 0,015 mg/0,06 mg Coated tablet professional information leaflet below is the property of Bayer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
